|
시장보고서
상품코드
2077224
인실리코 임상시험 시장 : 치료 영역별, 산업별, 시험 단계별, 지역별In Silico Clinical Trials Market, By Therapeutic Area, By Industry, By Phase, And By Geography |
||||||
인실리코 임상시험 시장은 2026년에 42억 9,760만 달러 규모에 이를 것으로 추정되고 있어 2033년까지 74억 3,720만 달러에 이를 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 8.2%로 성장할 전망입니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 42억 9,760만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) | 8.20% | 예측 금액(2033년) | 74억 3,720만 달러 |
인실리코(in silico) 임상시험이란, 신약이나 새로운 의료기기의 안전성 및 유효성을 검증하기 위해 가상 코호트를 형성하는 환자 특이적 모델의 개발을 의미합니다. 인실리코 임상시험은 신약 및 의료기기의 평가에 있어 중요한 역할을 하고 있습니다.
시장 역학:
만성 질환, 감염증, 신경 질환의 유병률 증가, 의료기기 시험에서 인실리코 모델의 활용 확대, 인실리코 임상시험 건수 증가, 그리고 높은 비용 대비 효과와 시험 중단 가능성이 낮다는 점이 전 세계 인실리코 임상시험 시장의 성장을 견인할 것으로 예상되는 주요 요인입니다.
예를 들어, 2022년 3월, 4P-Pharma는 광범위한 실세계 데이터(RWD)와 상세한 분자 수준의 의약품 데이터를 기반으로 한 독자적인 인실리코 접근법을 통해 임상시험 시뮬레이션을 수행하는 데이터 사이언스 분야 스타트업인 QuantHealth와 제휴 계약을 체결했습니다. 4P-Pharma사와 QuantHealth사는 공동으로 각자의 주력 후보 약물에 대해 인실리코 임상시험을 실시할 예정입니다. 이번 제휴는 당사의 스핀오프 기업인 4Moving Biotech가 개발 중인, 동종 최초의 퇴행성 관절염 치료제 '4P004'의 2상 임상시험에 대한 인실리코 시뮬레이션부터 시작됩니다.
본 보고서의 주요 특징
- 본 보고서는 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 시장 성장 촉진요인 및 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업들이 채택하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
- 전 세계 인실리코 임상시험 시장의 주요 기업 프로파일을 각종 지표(기업 개요, 제품 포트폴리오, 주요 동향, 재무 실적, 전략 등)를 바탕으로 소개했습니다.
- 본 보고서의 인사이트를 바탕으로, 마케팅 담당자와 기업 경영진은 향후 제품 출시, 기술 업데이트, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- '세계 인실리코 임상시험 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 재무 분석가 등 이 업계의 다양한 이해관계자들을 대상으로 합니다.
- 이해관계자들은 전 세계 인실리코 임상시험 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 할 수 있습니다.
목차
제1장 분석 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 인실리코 임상시험 시장
제5장 세계의 인실리코 임상시험 시장 : 치료 영역별(2021-2033년)
제6장 세계의 인실리코 임상시험 시장 : 산업별(2021-2033년)
제7장 세계의 인실리코 임상시험 시장 : 시험 단계별(2021-2033년)
제8장 세계의 인실리코 임상시험 시장 : 지역별(2021-2033년)
제9장 경쟁 구도
제10장 섹션
JHS 26.07.13In Silico Clinical Trials Market is estimated to be valued at USD 4,297.6 Mn in 2026 and is expected to reach USD 7,437.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.2% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 4,297.6 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.20% | 2033 Value Projection: | USD 7,437.2 Mn |
In silico clinical trials refers to the development of a patient-specific models to form virtual cohorts for testing the safety and efficacy of new drugs and of new medical devices. In silico clinical trials play an important role in the evaluation of new drugs and medical devices.
Market Dynamics:
Increase in prevalence of chronic, infectious, and neurological diseases, increasing use of in silico models to test medical devices, increase in number of in silico clinical trials, and cost-effectiveness and less chances of termination of the trial are major factors expected to propel the growth of the global in silico clinical trials market.
For instance, in March 2022, 4P-Pharma signed a partnership with QuantHealth, a data science start-up taking a unique in-silico approach to clinical trial simulations based on broad real-world data (RWD) and deep molecular drug data. Together, 4P-Pharma and QuantHealth will conduct in silico clinical trials of their lead drug candidates. The partnership will start with in-silico simulation of the phase II clinical trial of 4P004, a first-in-class disease modifying osteoarthritis drug, which is developed by our spin-off, 4Moving Biotech.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global in silico clinical trials market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Abzena Ltd., Clarivate, Immunetrics Inc., GNS Healthcare, Dassault Systemes, Evotec, Novadiscovery, Insilico Medicine Inc., and InSilicoTrials Technologies, among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global in silico clinical trials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global in silico clinical trials market.
Detailed Segmentation:
- Global In Silico Clinical Trials Market, By Therapeutic Area (Revenue, USD Mn, 2021 - 2033)
- Oncology
- Infectious Disease
- Cardiology
- Neurology
- Diabetes
- Other Therapeutic Areas
- Global In Silico Clinical Trials Market, By Industry (Revenue, USD Mn, 2021 - 2033)
- Medical Devices
- Pharmaceutical
- Global In Silico Clinical Trials Market, By Phase (Revenue, USD Mn, 2021 - 2033)
- Phase I
- Phase II
- Phase III
- Phase IV
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles:
- Abzena Ltd.
- Clarivate
- Immunetrics Inc.
- GNS Healthcare
- Dassault Systemes
- Evotec
- Novadiscovery
- Insilico Medicine Inc.
- InSilicoTrials Technologies
Table of Contents:
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Therapeutic Area
- Market Snapshot, By Industry
- Market Snapshot, By Phase
- Market Snapshot, By Geography
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- High prevalence of chronic, infectious, and neurological diseases
- Unavailability of complex testing centers
- Increase in number of in silico clinical trials worldwide
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER€(TM)s Analysis
- Merger and Acquisition Scenario
4. Global In Silico Clinical Trials Market
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global In Silico Clinical Trials Market, By Therapeutic Area, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Infectious Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Other Therapeutic Areas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
6. Global In Silico Clinical Trials Market, By Industry, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Medical Devices
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Pharmaceutical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
7. Global In Silico Clinical Trials Market, By Phase, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Phase I
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Phase II
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Phase III
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Phase IV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
8. Global In Silico Clinical Trials Market, By Geography, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Middle East and Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
9. Competitive Landscape
- Abzena Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Clarivate
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Immunetrics Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GNS Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Dassault Systemes
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Evotec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novadiscovery
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Insilico Medicine Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- InSilicoTrials Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
10. Section
- Research Methodology
- About us
